文献速递肿瘤 PET/CT

前列腺癌优势病灶动态[18F]DCFPyL PET动力学分析及与[18F]氟胆碱PET比较

Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [18F]DCFPyL-PET: comparison to [18F]fluorocholine-PET.
PubMed 文献 · EJNMMI Res · 2021-01-04

本研究对19例和23例前列腺癌患者分别行动态[18F]DCFPyL和[18F]FCH PET(总成像22分钟),比较肿瘤与良性组织的SUV及动力学参数。结果显示[18F]DCFPyL的Ki和k4可区分肿瘤与良性组织(敏感度84.2%、特异度94.7%),而[18F]FCH仅SUV有预测价值(敏感度82.6%、特异度87.0%)。22分钟动态[18F]DCFPyL PET可准确检测优势病灶,无需延迟成像。

要点

  • 22分钟动态[18F]DCFPyL PET可检测前列腺癌优势病灶,敏感度84.2%、特异度94.7%。
  • [18F]FCH仅SUV能区分肿瘤与良性组织,敏感度82.6%、特异度87.0%。
  • [18F]DCFPyL在良性组织k4/k3更高(洗脱更快),解释其更优肿瘤对比度。

核心结论

  • 22分钟动态[18F]DCFPyL PET检测前列腺癌优势病灶具有良好敏感度和特异度,且无需延迟注射后成像时间点。
  • [18F]DCFPyL与[18F]FCH不同的体内动力学行为可解释两者SUV图像的差异。

研究设计与样本

  • 19例前列腺癌患者行动态[18F]DCFPyL PET,23例行动态[18F]FCH PET,总成像时间均为22分钟,采集多帧(10至180秒)。
  • 以穿刺活检识别的肿瘤与良性组织区域为对象,比较SUV及时间-放射性曲线动力学参数。

主要发现

  • 逻辑回归显示[18F]DCFPyL的Ki和k4为区分肿瘤与良性组织的最优模型(敏感度84.2%、特异度94.7%)。
  • [18F]FCH仅SUV有预测价值(敏感度82.6%、特异度87.0%)。
  • [18F]FCH的k3(结合)高于[18F]DCFPyL,解释其SUV在注射后数分钟内即可区分肿瘤与良性组织。
  • [18F]DCFPyL在良性组织的k4/k3高于肿瘤组织(洗脱更快),解释其更优的肿瘤对比度。

关键数值与推荐

  • [18F]DCFPyL动力学模型区分肿瘤与良性组织:敏感度84.2%、特异度94.7%。
  • [18F]FCH SUV区分肿瘤与良性组织:敏感度82.6%、特异度87.0%。
  • 动态成像协议总时间22分钟,采集帧时长10至180秒。

临床怎么用

  • 可采用22分钟动态[18F]DCFPyL PET检测和定位前列腺癌优势病灶,无需延迟注射后成像。
  • 动力学参数Ki和k4有助于提高[18F]DCFPyL区分肿瘤与良性组织的能力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Identification of the dominant intraprostatic lesion(s) (DILs) can facilitate diagnosis and treatment by targeting biologically significant intra-prostatic foci. A PSMA ligand, [18F]DCFPyL (2-(3-{1-carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid), is better than choline-based [18F]FCH (fluorocholine) in detecting and localizing DIL because of higher tumour contrast, particularly when imaging is delayed to 1 h post-injection. The goal of this study was to investigate whether the different imaging performance of [18F]FCH and [18F]DCFPyL can be explained by their kinetic behaviour in prostate cancer (PCa) and to evaluate whether DIL can be accurately detected and localized using a short duration dynamic positron emission tomography (PET). METHODS: 19 and 23 PCa patients were evaluated with dynamic [18F]DCFPyL and [18F]FCH PET, respectively. The dynamic imaging protocol with each tracer had a total imaging time of 22 min and consisted of multiple frames with acquisition times from 10 to 180 s. Tumour and benign tissue regions identified by sextant biopsy were compared using standardized uptake value (SUV) and tracer kinetic parameters from kinetic analysis of time-activity curves. RESULTS: For [18F]DCFPyL, logistic regression identified Ki and k4 as the optimal model to discriminate tumour from benign tissue (84.2% sensitivity and 94.7% specificity), while only SUV was predictive for [18F]FCH (82.6% sensitivity and 87.0% specificity). The higher k3 (binding) of [18F]FCH than [18F]DCFPyL explains why [18F]FCH SUV can differentiate tumour from benign tissue within minutes of injection. Superior [18F]DCFPyL tumour contrast was due to the higher k4/k3 (more rapid washout) in benign tissue compared to tumour tissue. CONCLUSIONS: DIL was detected with good sensitivity and specificity using 22-min dynamic [18F]DCFPyL PET and avoids the need for delayed post-injection imaging timepoints. The dissimilar in vivo kinetic behaviour of [18F]DCFPyL and [18F]FCH could explain their different SUV images. Clinical Trial Registration NCT04009174 (ClinicalTrials.gov).

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Yang DM, Li F, Bauman G, et al. Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [18F]DCFPyL-PET: comparison to [18F]fluorocholine-PET. EJNMMI Res. 2021. PMID: 33394284. doi:10.1186/s13550-020-00735-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。